Product Description
| Brand |
Snibe |
| Sample Type |
Serum |
| Pack Size |
100T |
| CAT No. |
30201004M |
| Application |
Cancer Marker |
The kit has been designed for the quantitative determination of Total Prostate Specific Antigen Total (PSA) in human serum.
The method can be used for samples over the range of 0.02-400 ng/ml. The test has to be performed on the Fully-auto chemiluminescence immunoassay (CLIA) analyzer MAGLUMI (Including Maglumi 600,Maglumi 1000,Maglumi 1000 Plus, Maglumi 2000,Maglumi 2000 Plus,Maglumi 3000 and Maglumi 4000).
Advanced Chemiluminescent TechnologyLeveraging CLIA technology, the MAGLUMI Total PSA assay delivers highly accurate and sensitive results. This approach is key for early detection and precise monitoring of prostate cancer, providing confidence in every patient result. The system streamlines workflow and minimizes the risk of manual error.
Fast and Reliable QuantificationWith an assay time of approximately 35 minutes and fully automated operation, laboratories benefit from rapid turnaround and high throughput. This enables clinical teams to efficiently manage large volumes while maintaining accuracy for each PSA test.
Quality Assurance and TraceabilityEach PSA kit includes two-point calibrators, controls, and is subject to strict lot traceability via batch numbers. Regular calibration every four weeks ensures sustained accuracy and reliability throughout the shelf life, supporting quality laboratory practices.
FAQ's of Snibe MAGLUMI Total PSA (CLIA):
Q: How is the Snibe MAGLUMI Total PSA (CLIA) used in the laboratory?
A: The MAGLUMI Total PSA assay is performed on human serum samples using compatible MAGLUMI series immunoassay analyzers. The process involves loading the reagent kit, controls, and calibrators, after which the analyzer delivers quantitative PSA results automatically within approximately 35 minutes.
Q: What sample type is required for this PSA test?
A: This assay specifically requires human serum samples. It is important to follow recommended sample collection and handling procedures to ensure accurate and reliable results.
Q: When should calibration be performed on this assay?
A: The MAGLUMI Total PSA (CLIA) uses a two-point calibration system. Recalibration is recommended every four weeks or when changing reagent lots to maintain optimal assay accuracy.
Q: Where can the Snibe MAGLUMI Total PSA assay be utilized?
A: This PSA testing kit is designed for use in clinical laboratories, hospitals, and diagnostic centers by professional laboratory technicians. It is not intended for home or point-of-care use.
Q: What benefits does this assay offer for PSA monitoring?
A: The assay provides high sensitivity for early prostate cancer detection and high specificity for total PSA, ensuring precise quantification. Fast assay time and fully automated operation allow for efficient workflow and timely clinical decisions.
Q: How should the reagent kit be stored to maintain its quality?
A: Store the reagent kit at 2-8C and keep it away from sunlight. Adhering to these conditions helps maintain reagent stability and preserves the kit's shelf life of up to 12 months.
Q: What are the features that ensure reliable results with this product?
A: Key features include high throughput, a wide measurement range (0.2-100 ng/mL), low CV (within-run precision <10%), robust lot traceability, and digital result output on compatible analyzers.